2 research outputs found

    ΠžΠ‘ΠžΠ‘Π•ΠΠΠžΠ‘Π’Π˜ ΠŸΠžΠ ΠΠ–Π•ΠΠ˜Π― Π‘Π˜Π“ΠΠΠ›Π¬ΠΠ«Π₯ Π›Π˜ΠœΠ€ΠΠ’Π˜Π§Π•Π‘ΠšΠ˜Π₯ Π£Π—Π›ΠžΠ’ ПРИ ΠŸΠ•Π Π’Π˜Π§ΠΠžΠ™ ΠœΠ•Π›ΠΠΠžΠœΠ• ΠšΠžΠ–Π˜

    Get PDF
    Introduction. Each tenth tumor of skin is melanoma. Presence of tumor cells in sentinel lymph node influenced the medical tactics.The objective of the research was to study the metastasis of skin melanoma into the clinically negative regional lymph nodes.Material and methods. Histological, immunohistochemical, cytological and immunocytochemical methods were used to study biopsies of regional lymph nodes in 60 patients with skin melanoma.Results. 5 % of patients were diagnosed with melanoma in situ, 15 % – Π’1, 28.3 % – Π’2, 23.3 % – Π’3, 28.3 % – Π’4. At outflow of the lymph through 1 collector, the metastases in sentinel lymph node (SLN) was defined in 51 %, through 2 collectors – in 81.8 % of cases. Tumor cells damaged single lymph node in 35.3 % of cases, two and more lymph nodes in 64.7 % of cases. Metastases in SLN with formation of secondary tumor at the T1 melanoma were observed at 11.1 %, T2 – 5.9 %, T3 – 21.4 %, T4 – 47.1 % of studies. Clusters of cells or isolated cells of melanoma in SLN at Π’1 were noted in 22.2 %, at Π’2 – in 41.2 %, at Π’3 – in 42.9 %, at Π’4 – in 35.3 % of cases. At outflow of lymph through 1 collector, metastasises of melanoma in non-sentinel lymph nodes (NSLN) were revealed in 24 %, through 2 collectors – in 44.4 % of cases. Secondary changes of NSLN were noted in 16.7 % of cases of defeat of single SLN, in 31.8 % of cases of defeat of two and more SLN. Metastases of melanoma were revealed in 69.2 % of cases of formation of secondary tumor and in 4.8 % of cases of presence of clusters in SLN in removed NSLN.Conclusion. At increase of Π’melanoma of the skin, the quantity of sentinel lymph nodes with reactive changes decreased, and their number with metastases increased. Metastatic defeat of sentinel lymph nodes at outflow of lymph through 2 lymph collectors in two and more SLN and NSLN exceeded the defeat of SLN at outflow of lymph through 1 lymph collector in single lymph nodes. The use of immunocytochemical method of research allowed to expand pathomorphological verification of metastatic defeat of sentinel lymph nodes by 66.7%.Π’Π²Π΅Π΄Π΅Π½ΠΈΠ΅. КаТдая 10-я ΠΎΠΏΡƒΡ…ΠΎΠ»ΡŒ ΠΊΠΎΠΆΠΈ – ΠΌΠ΅Π»Π°Π½ΠΎΠΌΠ°, Π½Π° ΠΏΠ»Π°Π½ лСчСния ΠΊΠΎΡ‚ΠΎΡ€ΠΎΠΉ влияСт Π½Π°Π»ΠΈΡ‡ΠΈΠ΅ ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅Π²Ρ‹Ρ… ΠΊΠ»Π΅Ρ‚ΠΎΠΊ Π² сигнальном Π»ΠΈΠΌΡ„ΠΎΡƒΠ·Π»Π΅.ЦСль исслСдования – ΠΈΠ·ΡƒΡ‡Π΅Π½ΠΈΠ΅ мСтастазирования ΠΌΠ΅Π»Π°Π½ΠΎΠΌΡ‹ ΠΊΠΎΠΆΠΈ Π² клиничСски Π½Π΅Π³Π°Ρ‚ΠΈΠ²Π½Ρ‹Π΅ Ρ€Π΅Π³ΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹Π΅ лимфатичСскиС ΡƒΠ·Π»Ρ‹.ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π» ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. ГистологичСским, иммуногистохимичСским, цитологичСским ΠΈ иммуноцитохимичСским ΠΌΠ΅Ρ‚ΠΎΠ΄Π°ΠΌΠΈ исслСдованы Π±ΠΈΠΎΠΏΡ‚Π°Ρ‚Ρ‹ Ρ€Π΅Π³ΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹Ρ… лимфатичСских ΡƒΠ·Π»ΠΎΠ² 60 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с ΠΌΠ΅Π»Π°Π½ΠΎΠΌΠΎΠΉ ΠΊΠΎΠΆΠΈ.Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. Π£ 5 % ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² диагностирована ΠΌΠ΅Π»Π°Π½ΠΎΠΌΠ° Π² стадии in situ, Ρƒ 15 % – Π’1, Ρƒ 28,3 % – Π’2, Ρƒ 23,3 % – Π’3, Ρƒ 28,3 % – Π’4. ΠŸΡ€ΠΈ ΠΎΡ‚Ρ‚ΠΎΠΊΠ΅ Π»ΠΈΠΌΡ„Ρ‹ Ρ‡Π΅Ρ€Π΅Π· 1 Π»ΠΈΠΌΡ„ΠΎΠΊΠΎΠ»Π»Π΅ΠΊΡ‚ΠΎΡ€ мСтастазы Π² сигнальном Π»ΠΈΠΌΡ„ΠΎΡƒΠ·Π»Π΅ (Π‘Π›Π£) ΠΎΠΏΡ€Π΅Π΄Π΅Π»ΠΈΠ»ΠΈ Π² 51 %, Ρ‡Π΅Ρ€Π΅Π· 2 Π»ΠΈΠΌΡ„ΠΎΠΊΠΎΠ»Π»Π΅ΠΊΡ‚ΠΎΡ€Π° – Π² 81,8 % случаСв. Π’ 35,3 % случаСв ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅Π²Ρ‹Π΅ ΠΊΠ»Π΅Ρ‚ΠΊΠΈ ΠΏΠΎΡ€Π°ΠΆΠ°Π»ΠΈ Π΅Π΄ΠΈΠ½ΠΈΡ‡Π½Ρ‹ΠΉ Π»ΠΈΠΌΡ„ΠΎΡƒΠ·Π΅Π», Π² 64,7 % – 2 ΠΈ Π±ΠΎΠ»Π΅Π΅ Π»ΠΈΠΌΡ„ΠΎΡƒΠ·Π»Π°. ΠœΠ΅Ρ‚Π°ΡΡ‚Π°Π·Ρ‹ Π² Π‘Π›Π£ с Ρ„ΠΎΡ€ΠΌΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Π²Ρ‚ΠΎΡ€ΠΈΡ‡Π½ΠΎΠΉ ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ ΠΏΡ€ΠΈ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΠ΅ Π’1 наблюдали Π² 11,1 %, Π’2 – Π² 5,9 %, Π’3 – Π² 21,4 %, Π’4 – Π² 47,1 % исслСдований. БкоплСния ΠΊΠ»Π΅Ρ‚ΠΎΠΊ ΠΏΠΎ Ρ‚ΠΈΠΏΡƒ кластСра ΠΈΠ»ΠΈ Ρ€Π°Π·Ρ€ΠΎΠ·Π½Π΅Π½Π½Ρ‹Π΅ ΠΊΠ»Π΅Ρ‚ΠΊΠΈ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΡ‹ Π² Π‘Π›Π£ ΠΏΡ€ΠΈ Π’1 ΠΎΡ‚ΠΌΠ΅Ρ‡Π΅Π½Ρ‹ Π² 22,2 %, ΠΏΡ€ΠΈ Π’2 – Π² 41,2 %, ΠΏΡ€ΠΈ Π’3 – Π² 42,9 %, ΠΏΡ€ΠΈ Π’4 – Π² 35,3 % случаСв. ΠŸΡ€ΠΈ ΠΎΡ‚Ρ‚ΠΎΠΊΠ΅ Π»ΠΈΠΌΡ„Ρ‹ Ρ‡Π΅Ρ€Π΅Π· 1 ΠΊΠΎΠ»Π»Π΅ΠΊΡ‚ΠΎΡ€ мСтастазы ΠΌΠ΅Π»Π°Π½ΠΎΠΌΡ‹ Π² Π½Π΅ΡΠΈΠ³Π½Π°Π»ΡŒΠ½Ρ‹Ρ… Π»ΠΈΠΌΡ„ΠΎΡƒΠ·Π»Π°Ρ… (НБЛУ) выявлСны Π² 24 %, Ρ‡Π΅Ρ€Π΅Π· 2 ΠΊΠΎΠ»Π»Π΅ΠΊΡ‚ΠΎΡ€Π° – Π² 44,4 % случаСв. Π’Ρ‚ΠΎΡ€ΠΈΡ‡Π½Ρ‹Π΅ измСнСния НБЛУ ΠΎΡ‚ΠΌΠ΅Ρ‚ΠΈΠ»ΠΈ Π² 16,7 % случаСв пораТСния Π΅Π΄ΠΈΠ½ΠΈΡ‡Π½ΠΎΠ³ΠΎ Π‘Π›Π£, Π² 31,8 % наблюдСний – пораТСния 2 ΠΈ Π±ΠΎΠ»Π΅Π΅ Π‘Π›Π£. Π’ 69,2 % случаСв формирования Π²Ρ‚ΠΎΡ€ΠΈΡ‡Π½ΠΎΠΉ ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ ΠΈ Π² 4,8 % наличия кластСров Π² Π‘Π›Π£ Π² ΡƒΠ΄Π°Π»Π΅Π½Π½Ρ‹Ρ… НБЛУ ΠΎΠ±Π½Π°Ρ€ΡƒΠΆΠ΅Π½Ρ‹ мСтастазы ΠΌΠ΅Π»Π°Π½ΠΎΠΌΡ‹.Π’Ρ‹Π²ΠΎΠ΄Ρ‹. ΠŸΡ€ΠΈ нарастании Π’ ΠΌΠ΅Π»Π°Π½ΠΎΠΌΡ‹ ΠΊΠΎΠΆΠΈ ΡƒΠΌΠ΅Π½ΡŒΡˆΠ°Π»ΠΎΡΡŒ число ΡΠΈΠ³Π½Π°Π»ΡŒΠ½Ρ‹Ρ… лимфатичСских ΡƒΠ·Π»ΠΎΠ² с Ρ€Π΅Π°ΠΊΡ‚ΠΈΠ²Π½Ρ‹ΠΌΠΈ измСнСниями, ΠΈ возрастала ΠΈΡ… Ρ‡ΠΈΡΠ»Π΅Π½Π½ΠΎΡΡ‚ΡŒ с мСтастазами. ΠœΠ΅Ρ‚Π°ΡΡ‚Π°Ρ‚ΠΈΡ‡Π΅ΡΠΊΠΎΠ΅ ΠΏΠΎΡ€Π°ΠΆΠ΅Π½ΠΈΠ΅ ΡΠΈΠ³Π½Π°Π»ΡŒΠ½Ρ‹Ρ… лимфатичСских ΡƒΠ·Π»ΠΎΠ² ΠΏΡ€ΠΈ ΠΎΡ‚Ρ‚ΠΎΠΊΠ΅ Π»ΠΈΠΌΡ„Ρ‹ Ρ‡Π΅Ρ€Π΅Π· 2 Π»ΠΈΠΌΡ„ΠΎΠΊΠΎΠ»Π»Π΅ΠΊΡ‚ΠΎΡ€Π° Π² 2 ΠΈ Π±ΠΎΠ»Π΅Π΅ Π‘Π›Π£ ΠΈ НБЛУ ΠΏΡ€Π΅Π²Ρ‹ΡˆΠ°Π»ΠΎ ΠΏΠΎΡ€Π°ΠΆΠ΅Π½ΠΈΠ΅ Π‘Π›Π£ ΠΏΡ€ΠΈ ΠΎΡ‚Ρ‚ΠΎΠΊΠ΅ Π»ΠΈΠΌΡ„Ρ‹ Ρ‡Π΅Ρ€Π΅Π· 1 Π»ΠΈΠΌΡ„ΠΎΠΊΠΎΠ»Π»Π΅ΠΊΡ‚ΠΎΡ€ Π² Π΅Π΄ΠΈΠ½ΠΈΡ‡Π½Ρ‹Π΅ Π»ΠΈΠΌΡ„ΠΎΡƒΠ·Π»Ρ‹. ИспользованиС иммуноцитохимичСского ΠΌΠ΅Ρ‚ΠΎΠ΄Π° исслСдования ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΠ»ΠΎ Π½Π° 66,7 % Ρ€Π°ΡΡˆΠΈΡ€ΠΈΡ‚ΡŒ ΠΏΠ°Ρ‚ΠΎΠΌΠΎΡ€Ρ„ΠΎΠ»ΠΎΠ³ΠΈΡ‡Π΅ΡΠΊΡƒΡŽ Π²Π΅Ρ€ΠΈΡ„ΠΈΠΊΠ°Ρ†ΠΈΡŽ мСтастатичСского пораТСния ΡΠΈΠ³Π½Π°Π»ΡŒΠ½Ρ‹Ρ… лимфатичСских ΡƒΠ·Π»ΠΎΠ²

    FEATURES OF DEFEATS OF SENTINEL LYMPH NODES AT PRIMARY MELANOMA OF SKIN

    Get PDF
    Introduction. Each tenth tumor of skin is melanoma. Presence of tumor cells in sentinel lymph node influenced the medical tactics.The objective of the research was to study the metastasis of skin melanoma into the clinically negative regional lymph nodes.Material and methods. Histological, immunohistochemical, cytological and immunocytochemical methods were used to study biopsies of regional lymph nodes in 60 patients with skin melanoma.Results. 5 % of patients were diagnosed with melanoma in situ, 15 % – Π’1, 28.3 % – Π’2, 23.3 % – Π’3, 28.3 % – Π’4. At outflow of the lymph through 1 collector, the metastases in sentinel lymph node (SLN) was defined in 51 %, through 2 collectors – in 81.8 % of cases. Tumor cells damaged single lymph node in 35.3 % of cases, two and more lymph nodes in 64.7 % of cases. Metastases in SLN with formation of secondary tumor at the T1 melanoma were observed at 11.1 %, T2 – 5.9 %, T3 – 21.4 %, T4 – 47.1 % of studies. Clusters of cells or isolated cells of melanoma in SLN at Π’1 were noted in 22.2 %, at Π’2 – in 41.2 %, at Π’3 – in 42.9 %, at Π’4 – in 35.3 % of cases. At outflow of lymph through 1 collector, metastasises of melanoma in non-sentinel lymph nodes (NSLN) were revealed in 24 %, through 2 collectors – in 44.4 % of cases. Secondary changes of NSLN were noted in 16.7 % of cases of defeat of single SLN, in 31.8 % of cases of defeat of two and more SLN. Metastases of melanoma were revealed in 69.2 % of cases of formation of secondary tumor and in 4.8 % of cases of presence of clusters in SLN in removed NSLN.Conclusion. At increase of Π’melanoma of the skin, the quantity of sentinel lymph nodes with reactive changes decreased, and their number with metastases increased. Metastatic defeat of sentinel lymph nodes at outflow of lymph through 2 lymph collectors in two and more SLN and NSLN exceeded the defeat of SLN at outflow of lymph through 1 lymph collector in single lymph nodes. The use of immunocytochemical method of research allowed to expand pathomorphological verification of metastatic defeat of sentinel lymph nodes by 66.7%
    corecore